Smart Pills Market Size, Share & Trends Analysis Report By Indication (Celiac Disease, Small Bowel Diseases, Colon Cancer, Others), By Application (Capsule Endoscopy, Drug Delivery, Vital Sign Monitoring), By End User (Hospitals and Clinics, Diagnostic Centers) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Smart Pills Market Size & Growth Analysis

The global smart pills market size was valued at USD 2.57 billion in 2025 and is projected to grow from USD 2.86 billion in 2026 to USD 6.78 billion by 2034, registering a CAGR of 11.38% during the forecast period from 2026 to 2034. North America dominated the smart pills market with a market share of 40.52% in 2025.

The global smart pills market encompasses a broad range of technologies designed to enable non-invasive diagnostics, targeted drug delivery, and real-time monitoring of gastrointestinal and systemic conditions, thereby improving patient outcomes and clinical efficiency. By indication, the market includes celiac disease, small bowel diseases, colon cancer, and others, with small bowel diseases leading the segment due to the increasing adoption of capsule endoscopy for early diagnosis and monitoring. By application, the market is classified into capsule endoscopy, drug delivery, and vital sign monitoring, where capsule endoscopy holds a high share owing to its ability to provide minimally invasive visualization of the gastrointestinal tract. By end user, smart pills are utilized in hospitals and clinics, as well as diagnostic centers, with hospitals and clinics accounting for the major share, as they serve as the primary point for administering smart pill technologies and integrating them into patient care workflows.

Indication Insights

The celiac disease segment dominated the market in 2025 with a revenue share of 33.18%. The growth is attributed to the rising gluten-related disorders, growing public awareness and screening programs for celiac disease, as well as increasing healthcare investments.

The small bowel diseases are anticipated to register the fastest CAGR of 12.12% during the forecast period, owing to the increasing adoption of capsule endoscopy for diagnosing conditions such as Crohn’s disease, obscure gastrointestinal bleeding, and small bowel tumors. These conditions often present challenges for traditional diagnostic methods, making capsule endoscopy a valuable tool in clinical practice.

Request Customizationto receive a tailored report.

Application Insights

The drug delivery segment is anticipated to grow at a CAGR of 12.96% from 2026-2034. This growth is attributed to advancements in smart drug delivery systems, integration of AI in smart pill devices, and a favourable regulatory framework, which further accelerates the adoption of advanced smart pill technologies.

The capsule endoscopy dominated the market with a revenue share of 53.3%, due to its non-invasive nature and the ability to provide detailed imaging of the gastrointestinal tract, particularly the small intestine, which is challenging to visualize using traditional endoscopic methods.

End User Insights

The diagnostic centers dominated the market in 2025. The growth is attributed to their ability to offer cost-efficient and quick diagnostic services, the rising number of outpatient visits for gastrointestinal evaluations, and the adoption of smart pill technologies for early disease detection and monitoring, which reduces the requirement for hospitalization.

The hospital and clinics segment is anticipated to register the fastest CAGR of 12.58% during the forecast period, owing to the increasing adoption of smart pills for non-invasive diagnostics, growing patient volume in gastrointestinal and related disorders, and the availability of advanced clinical infrastructure that facilitates seamless integration of these technologies into routine care.

Speak to an Analystto discuss market opportunities.

Regional Analysis

The North America region dominated the market with a revenue share of 40.52% in 2025. The growth is attributed to factors such as improved reimbursement rates, which facilitate the adoption of smart pill technologies in clinical settings, and a high consumer base with increasing openness to adopt advanced medical technologies.

The smart pills market in the U.S. is widely driven by the establishment of the Digital Health Center of Excellence by the U.S. FDA in January 2025. This initiative streamlines regulatory processes for digital health innovations, including smart pills, by offering tailored guidance and support. By facilitating faster approvals and clearer pathways, the center accelerates market entry for new smart pill technologies, thereby expanding the market size and fostering sustained market growth.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Market Insights

The Asia Pacific region is the fastest-growing region with a CAGR of 12.52% during the forecast timeframe, owing to factors such as national colorectal and GI screening programs, rapid telehealth adoption, and expanding private diagnostics.

India continues to position itself in the smart pills market, due to the rising use of capsule endoscopy for diagnosing small bowel bleeding. Clinical studies have reported exceptionally high detection rates, ranging from 43% to 90%, for gastrointestinal lesions in over 2,300 patients using capsule endoscopy in India. This advancement is driving more hospitals to adopt capsule endoscopy technology, thereby expanding the market size and fueling global market growth.

Europe Market Insights

A growing trend in the European market is the integration of smart pills with wearable sensors and remote monitoring platforms, which allows continuous tracking of a patient’s gastrointestinal activity and vital parameters. This integration provides physicians with real-time, comprehensive data, improving the accuracy of diagnoses and enabling earlier detection of conditions such as Crohn’s disease, small bowel tumors, and colon cancer.

The smart pills market in the UK is propelling due to the NHS-approved research that has evaluated a Digital Medicine System that pairs an ingestible sensor-enabled medication, a wearable patch, and a mobile app to track ingestion and clinical status in psychiatric care. This smart pill approach links dosing data to outcomes, supporting adoption and market growth.

Middle East and Africa Market Insights

The market is growing due to the focus on medical tourism for advanced gastrointestinal diagnostics, which drives demand in countries like the UAE and South Africa. Hospitals are increasingly integrating smart pills with telemedicine platforms and remote monitoring systems, enabling physicians to track patient progress in real time without prolonged hospital stays.

Smart pills market growth in South Africa is increasing due to the supporting cost-efficient outpatient diagnostics by reducing the requirement for prolonged hospital stays and invasive procedures, which aligns with the country’s healthcare focus on outpatient and ambulatory care, particularly in managing gastrointestinal disorders.

Latin America Market Insights

In Latin America, the smart pills market is being driven by the growing adoption of telemedicine and remote patient monitoring, which allows healthcare providers to track gastrointestinal health and treatment outcomes in real time, particularly in underserved or remote regions, thereby improving access to advanced diagnostics and reducing the burden on centralized hospital facilities.

The Argentine smart pills market is witnessing steady expansion driven by the country’s growing focus on advanced diagnostic technologies and minimally invasive healthcare solutions. Several leading hospitals in Buenos Aires, such as the Hospital Italiano de Buenos Aires, have started adopting capsule endoscopy systems for early detection of gastrointestinal disorders, allowing physicians to visualize the digestive tract without invasive procedures. This shift toward non-invasive diagnostics reflects Argentina’s broader healthcare modernization efforts and growing acceptance of smart medical devices.

Competitive Landscape

The global smart pills market is moderately fragmented, with the major players driving capsule endoscopy adoption while numerous emerging companies contributing to innovative digital pill and sensor-based solutions.

PENTAX Medical: An emerging market player

PENTAX Medical is an emerging player in the global market, specializing in advanced endoscopic imaging and capsule endoscopy technologies to enhance gastrointestinal diagnostics.

• In January 2024, PENTAX Medical launched an innovative Digital Capture Module 9380 to transform medical recording competencies in ENT and speech language pathology settings, reflecting its commitment to digital innovation and precision imaging, the same expertise that drives its capsule endoscopy (smart pill) solutions for advanced gastrointestinal diagnostics.

List of Key and Emerging Players in Smart Pills Market